Description
Epilepsy Surgery Market Forecast till 2027
Market Overview
The global epilepsy surgery market is expected to register a notable CAGR of CAGR 5.72% during the review period to surpass USD 1,402.32 million by the end of 2027. The epilepsy surgery is accomplished to minimize the probability of seizures.
Developing business sectors are expected to offer potential development openings for worldwide market players working in the market because of mechanical progressions, the developing old populace inclined to seizure problems, and government drives in endeavor research initiatives on epilepsy medical procedures.
The epilepsy medical procedure market is projected to display critical development over the figure time frame, credited to variables like quick mechanical progressions in the gadgets, better clinical offices, and an expanding patient pool needing careful therapy.
The global epilepsy surgery market is expected to witness a healthy market expansion a significant growth rate owing to the growing incidences of neurological disorders leading to exclusive R&D on epilepsy treatment devices and growing prevalence of brain injuries because of growing road accidents.
Moreover, progresses in a robot-helped medical procedure and an increment in the geriatric populace are probably going to drive market development. Be that as it may, changes related to epilepsy surgeries may restrain the market development.
Market Segmentation
The epilepsy surgery market has been categorized into procedure type and ends user.
By procedure type the global market has been categorized into Resective surgery, Laser Interstitial Thermal Therapy (LITT), and others. In terms of end users, the market has been classified into hospitals & clinics, specialty centers, and others.
Regional Analysis
Geographically, the epilepsy medical procedure market, has been partitioned into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
The Americas is likely to command the epilepsy medical procedure market owing to different elements, like the accessibility of grounded medical services offices, the high pervasiveness of neurological issues, and the expanding rate of epilepsy.
North America is separated into the US and Canada. It is assessed that approximately 150,000 Americans are determined to have Central Nervous System (CNS) jumble that causes seizures and is the fourth most normal neurological infection.
With expanding interest in research and improvement, the creation of effective epilepsy meds, and a high pervasiveness of epilepsy, Europe has additionally developed as a noticeable market for epilepsy medical procedures.
The Asia-Pacific area offers rewarding freedoms for players in the epilepsy medical procedure market is driven by the presence of an enormous geriatric populace, legislative drives to further develop the medical care area, an increment in research and advancement exercises, and an increment in epilepsy occurrence in the region. The Middle East &Africa epilepsy medical procedure market is fragmented into significant areas, to be specific the Middle East, Africa, and Latin America.
Major Players
The prominent market players operating in the global Epilepsy surgeries market include Stryker (US), Intuitive Surgical (US), Medtronic Plc (Mazor Robotics) (Ireland), Cephalon, Inc. (US), CMR Surgical (UK), Natus Medical Incorporated (US), Zimmer Biomet Holdings Inc. (US), Auris Health, Inc. (Hansen Medical, Inc.) (US), Livanova Plc (UK), and Monteris Medical (US).
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.
Demand for surgical proceduresare expected to boost the growth of the global epilepsy surgery market at a CAGR of 5.72% during the forecast period 2021 to 2027
Table of Contents
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY
2.2 RESEARCH OBJECTIVE
2.3 MARKET STRUCTURE
2.4 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING PREVALENCE OF EPILEPSY AND DEMAND FOR SURGICAL PROCEDURES
4.2.2 RISING NUMBER OF CASES OF BRAIN INJURIES DUE TO ROAD ACCIDENTS
4.2.3 ADVANCEMENT AND ADOPTION OF ROBOT-ASSISTED SURGERY
4.3 RESTRAINT
4.3.1 STRINGENT GOVERNMENT REGULATIONS AND COMPLICATIONS ASSOCIATED WITH SURGERY
4.4 OPPORTUNITY
4.4.1 COLLABORATION WITH RESEARCH INSTITUTES FOR MARKET ENTRANTS TO ACCESS GLOBAL MARKETS
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION
5.1.4 MARKETING & SALES
5.2 PORTER’S FIVE FORCES MODEL
5.2.1 BARGAINING POWER OF BUYERS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTES
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19
5.3.1 IMPACT ON SUPPLY CHAIN
5.3.2 IMPACT ON DEMAND
5.3.3 AVAILABILITY AND ACCESS TO HEALTHCARE FACILITIES
5.3.4 IMPACT ON REVENUE AND STRATEGIC DECISIONS BY COMPANIES
6 GLOBAL EPILEPSY SURGERY MARKET BY PROCEDURE TYPE
6.1 OVERVIEW
6.2 RESECTIVE SURGERY
6.3 LASER INTERSTITIAL THERMAL THERAPY (LITT)
6.4 OTHERS
7 GLOBAL EPILEPSY SURGERY MARKET BY END USER
7.1 OVERVIEW
7.2 HOSPITALS & CLINICS
7.3 SPECIALTY CENTERS
7.4 OTHERS
8 GLOBAL EPILEPSY SURGERY MARKET, BY REGION
8.1 OVERVIEW
8.2 AMERICAS
8.2.1 NORTH AMERICA
8.2.1.1 US
8.2.1.2 CANADA
8.2.2 LATIN AMERICA
8.3 EUROPE
8.3.1 WESTERN EUROPE
8.3.1.1 GERMANY
8.3.1.2 UK
8.3.1.3 FRANCE
8.3.1.4 ITALY
8.3.1.5 SPAIN
8.3.1.6 REST OF WESTERN EUROPE
8.3.2 EASTERN EUROPE
8.4 ASIA PACIFIC
8.4.1 CHINA
8.4.2 JAPAN
8.4.3 INDIA
8.4.4 SOUTH KOREA
8.4.5 AUSTRALIA
8.4.6 REST OF ASIA PACIFIC
8.5 MIDDLE EAST & AFRICA
8.5.1 MIDDLE EAST
8.5.2 AFRICA
9 COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPETITIVE BENCHMARKING
9.3 MAJOR GROWTH STRATEGY IN THE GLOBAL EPILEPSY SURGERY MARKET
9.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL EPILEPSY SURGERY MARKET
9.5 KEY DEVELOPMENT ANALYSIS
9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
9.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL
9.6.2 MERGER/ACQUISITION
9.7 FINANCIAL MATRIX
9.7.1 SALES (USD MILLION), 2020
9.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2020
10 COMPANY PROFILES
10.1 STRYKER
10.1.1 COMPANY OVERVIEW
10.1.2 FINANCIAL OVERVIEW
10.1.3 PRODUCTS/SERVICES OFFERED
10.1.4 KEY DEVELOPMENTS
10.1.5 SWOT ANALYSIS
10.1.6 KEY STRATEGIES
10.2 ZIMMER BIOMET HOLDINGS INC.
10.2.1 COMPANY OVERVIEWS
10.2.2 FINANCIAL OVERVIEW
10.2.3 PRODUCTS/SERVICES OFFERED
10.2.4 KEY DEVELOPMENTS
10.2.5 SWOT ANALYSIS
10.2.6 KEY STRATEGIES
10.3 AURIS HEALTH, INC. (HANSEN MEDICAL, INC.)
10.3.1 COMPANY OVERVIEW
10.3.2 FINANCIAL OVERVIEW
10.3.3 PRODUCTS/SERVICES OFFERED
10.3.4 KEY DEVELOPMENTS
10.3.5 SWOT ANALYSIS
10.3.6 KEY STRATEGIES
10.4 INTUITIVE SURGICAL
10.4.1 COMPANY OVERVIEW
10.4.2 FINANCIAL OVERVIEW
10.4.3 PRODUCTS/SERVICES OFFERED
10.4.4 KEY DEVELOPMENTS
10.4.5 SWOT ANALYSIS
10.4.6 KEY STRATEGIES
10.5 MEDTRONIC PLC (MAZOR ROBOTICS)
10.5.1 COMPANY OVERVIEW
10.5.2 FINANCIAL OVERVIEW
10.5.3 PRODUCTS/SERVICES OFFERED
10.5.4 KEY DEVELOPMENTS
10.5.5 SWOT ANALYSIS
10.5.6 KEY STRATEGIES
10.6.4 KEY DEVELOPMENTS
10.7 CMR SURGICAL
10.7.1 COMPANY OVERVIEW
10.7.2 FINANCIAL OVERVIEW
10.7.3 PRODUCTS/SERVICES OFFERED
10.7.4 KEY DEVELOPMENTS
10.7.5 SWOT ANALYSIS
10.7.6 KEY STRATEGIES
10.8 NATUS MEDICAL INCORPORATED
10.8.1 COMPANY OVERVIEW
10.8.2 FINANCIAL OVERVIEW
10.8.3 PRODUCTS OFFERED
10.8.4 KEY DEVELOPMENTS
10.8.5 SWOT ANALYSIS
10.8.6 KEY STRATEGIES
10.9 LIVANOVA PLC
10.9.1 COMPANY OVERVIEW
10.9.2 FINANCIAL OVERVIEW
10.9.3 PRODUCTS OFFERED
10.9.4 KEY DEVELOPMENTS
10.9.5 SWOT ANALYSIS
10.9.6 KEY STRATEGIES
10.10 MONTERIS MEDICAL
10.10.1 COMPANY OVERVIEW
10.10.2 FINANCIAL OVERVIEW
10.10.3 PRODUCTS/SERVICES OFFERED
10.10.4 KEY DEVELOPMENTS
10.10.5 SWOT ANALYSIS
10.10.6 KEY STRATEGIES
11 APPENDIX
11.1 REFERENCES
11.2 RELATED REPORTS
